BrightHeart View Classifier vs Study Watch with Irregular Pulse Monitor (Home)

BrightHeart View Classifier integrates seamlessly into existing ultrasound workflows as a plug-and-play solution, providing real-time guidance via a cart-side tablet to enhance the detection of congenital heart defects and ensure exam completeness. This can lead to a reduction in incomplete fetal heart scans and patient recall rates. The Verily Study Watch, a prescription-only wearable, unobtrusively collects physiological data, including ECG and irregular pulse monitoring, for clinical research and healthcare use, aiding in the detection and management of atrial fibrillation.

BrightHeart View Classifier is compatible with major ultrasound manufacturers and existing reporting solutions, with results summarized and linked in reporting software, suggesting its analysis can be readily incorporated into current documentation practices. The Verily Study Watch utilizes cloud-based data processing with proprietary algorithms and machine learning, and its data platform is designed to ingest, harmonize, and curate data for research protocols, implying accessibility for integration into patient records.

BrightHeart View Classifier enhances the detection of congenital heart defects and flags potential structural abnormalities, while also ensuring exam completeness and consistency regardless of operator experience. Studies have shown its AI model can classify echocardiogram views with high accuracy, and it aims for expert-level screening. The Verily Study Watch provides on-demand single-channel ECG measurement and irregular pulse monitoring for atrial fibrillation (AFib) detection, with studies reporting high sensitivity (96.1%) and specificity (98.1%) for interval-level AF detection.

BrightHeart View Classifier is designed as a plug-and-play solution that ensures exam completeness and consistency regardless of operator experience, offering real-time guidance via a cart-side tablet, suggesting a low learning curve for sonographers. For the Verily Study Watch, while patient interaction is unobtrusive, physicians would need to interpret the cloud-based processed data from ECG and other physiological sensors, which is designed to be accurate and actionable.

The provided information for BrightHeart View Classifier does not explicitly detail security measures beyond its seamless integration into existing ultrasound workflows. For the Verily Study Watch, on-device data encryption is implemented for security, and all data stored on the watch are encrypted before being uploaded and processed in the cloud. Verily also adheres to industry-recognized frameworks and standards, implementing strong encryption (in-transit & at-rest) and tightly restricted role-based access.

BrightHeart View Classifier is a cloud-based, plug-and-play solution designed for seamless integration into existing ultrasound workflows and is compatible with major ultrasound manufacturers and reporting solutions, which could facilitate easier deployment across multiple sites. The Verily Study Watch, as a wearable device with cloud-based data processing, is designed for scalable collection of rich and complex datasets across clinical and observational studies, supporting remote monitoring and potentially expanding the pool of trial participants across geographies.

BrightHeart View Classifier features automatic detection and confirmation of standard fetal heart views and flags potential structural abnormalities, implying a record of these AI-driven actions, and generated DICOM files cannot be modified by the user. The provided information for the Verily Study Watch does not explicitly detail specific audit-trail features for tracking AI-generated findings or user modifications within a clinical oversight context, beyond data being securely transferred and viewed by an HCP via a web portal.